Capricor Therapeutics Insider Trades
NASDAQ: CAPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 13 · $8.37M
- Shares bought / sold
- 0 / 272.53K
- Net activity
- Net selling $8.4 million
Capricor Therapeutics insider activity
Over the last 12 months, Capricor Therapeutics insiders reported 32 transactions on SEC Form 4: 0 open-market purchases and 13 sales. Insiders bought $0 and sold $8.4 million worth of stock, for net insider selling of $8.4 million. The largest seller was Sabar Karimah Es, with $3.8 million in reported sales.
The most recent filing shows Krasney Karen (EVP, GENERAL COUNSEL) reporting a transaction in 24,100 shares at $3.18 on Jun 25, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CAPR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CAPR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 25, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Sale | 24,100 | $732.16K | Form 4 |
| Jun 25, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Option exercise | 24,100 | $76.64K | Form 4 |
| Jun 25, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Sale | 24,100 | $732.16K | Form 4 |
| Jun 25, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Option exercise | 24,100 | $76.64K | Form 4 |
| Jun 24, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Sale | 400 | $12.00K | Form 4 |
| Jun 24, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Option exercise | 400 | $1.27K | Form 4 |
| Jun 24, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Sale | 400 | $12.00K | Form 4 |
| Jun 24, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Option exercise | 400 | $1.27K | Form 4 |
| Jun 22, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Sale | 500 | $15.00K | Form 4 |
| Jun 22, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Option exercise | 500 | $1.59K | Form 4 |
| Jun 22, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Sale | 500 | $15.00K | Form 4 |
| Jun 22, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Option exercise | 500 | $1.59K | Form 4 |
| May 18, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Option exercise | 3,000 | $4.17K | Form 4 |
| May 13, 2026 | Litvack FrankDirector | Option exercise | 3,937 | $5.47K | Form 4 |
| May 1, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Sale | 25,000 | $792.54K | Form 4 |
| May 1, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Option exercise | 25,000 | $79.50K | Form 4 |
| May 1, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Sale | 25,000 | $792.55K | Form 4 |
| May 1, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Option exercise | 25,000 | $79.50K | Form 4 |
| Apr 2, 2026 | Sabar Karimah EsDirector | Sale | 7,529 | $240.93K | Form 4 |
| Apr 2, 2026 | Sabar Karimah EsDirector | Option exercise | 7,529 | $23.94K | Form 4 |
| Apr 1, 2026 | Sabar Karimah EsDirector | Sale | 53,735 | $1.67M | Form 4 |
| Apr 1, 2026 | Sabar Karimah EsDirector | Option exercise | 53,735 | $261.15K | Form 4 |
| Mar 31, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Sale | 25,000 | $752.93K | Form 4 |
| Mar 31, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Option exercise | 2,819 | $8.96K | Form 4 |
| Mar 31, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Option exercise | 21,488 | $80.37K | Form 4 |
| Mar 31, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Option exercise | 693 | $963.27 | Form 4 |
| Mar 31, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Sale | 25,000 | $753.15K | Form 4 |
| Mar 31, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Option exercise | 25,000 | $79.50K | Form 4 |
| Mar 31, 2026 | Sabar Karimah EsDirector | Sale | 61,265 | $1.85M | Form 4 |
| Mar 31, 2026 | Sabar Karimah EsDirector | Option exercise | 61,265 | $297.75K | Form 4 |
| Dec 30, 2025 | Krasney KarenEVP, GENERAL COUNSEL | Option exercise | 2,500 | $3.48K | Form 4 |
| Dec 19, 2025 | DUNBAR GEORGE W JRDirector | Option exercise | 3,000 | $4.17K | Form 4 |
| Mar 5, 2025 | Marban LindaCHIEF EXECUTIVE OFFICER | other | 12,500 | — | Form 4 |
| Mar 3, 2025 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Option exercise | 2,500 | $3.48K | Form 4 |
| Mar 3, 2025 | DUNBAR GEORGE W JRDirector | Option exercise | 750 | $1.04K | Form 4 |
| Mar 3, 2025 | Litvack FrankDirector | Tax withholding | 2,543 | $34.76K | Form 4 |
| Mar 3, 2025 | Litvack FrankDirector | Option exercise | 25,000 | $34.75K | Form 4 |
| Mar 3, 2025 | Marban LindaCHIEF EXECUTIVE OFFICER | Option exercise | 25,000 | $34.75K | Form 4 |
| Feb 27, 2025 | COLLIER EARL M JRDirector | Option exercise | 750 | $1.04K | Form 4 |
| Jan 2, 2025 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Award | 3,342 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4